COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION

Described are methods of treating viral disease using compounds that block inhibitory NK cell receptors, thereby reducing their inhibition of NK cell cytotoxicity in killing infected target cells. In one embodiment, the compound is an antibody binding, for example, one or more of the human KIR2DL1,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FRANCOIS ROMAGNE, PETER ANDREAS NICOLAI REUMERT WAGTMANN, JOAKIM GLAMANN
Format:	Patent
Sprache:	eng ; por
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	FRANCOIS ROMAGNE PETER ANDREAS NICOLAI REUMERT WAGTMANN JOAKIM GLAMANN
description	Described are methods of treating viral disease using compounds that block inhibitory NK cell receptors, thereby reducing their inhibition of NK cell cytotoxicity in killing infected target cells. In one embodiment, the compound is an antibody binding, for example, one or more of the human KIR2DL1, KIR2DL2, and KIR2DL3 receptors. In another embodiment, the method further comprises administering a therapeutic antibody or fusion protein which binds an antigen expressed on cells infected with the virus.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT1835937EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT1835937EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT1835937EE3</originalsourceid><addsrcrecordid>eNrjZDB19vcN8A_2DPH09wtWcPRzUfB1DfHwdwlWcPMPUggJcnUM8fRzVwjzDHL0UfD0c3N1BqnkYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxASGGFsamlsbmrq7GRCgBAL9CJ8o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION</title><source>esp@cenet</source><creator>FRANCOIS ROMAGNE ; PETER ANDREAS NICOLAI REUMERT WAGTMANN ; JOAKIM GLAMANN</creator><creatorcontrib>FRANCOIS ROMAGNE ; PETER ANDREAS NICOLAI REUMERT WAGTMANN ; JOAKIM GLAMANN</creatorcontrib><description>Described are methods of treating viral disease using compounds that block inhibitory NK cell receptors, thereby reducing their inhibition of NK cell cytotoxicity in killing infected target cells. In one embodiment, the compound is an antibody binding, for example, one or more of the human KIR2DL1, KIR2DL2, and KIR2DL3 receptors. In another embodiment, the method further comprises administering a therapeutic antibody or fusion protein which binds an antigen expressed on cells infected with the virus.</description><language>eng ; por</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120625&DB=EPODOC&CC=PT&NR=1835937E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120625&DB=EPODOC&CC=PT&NR=1835937E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FRANCOIS ROMAGNE</creatorcontrib><creatorcontrib>PETER ANDREAS NICOLAI REUMERT WAGTMANN</creatorcontrib><creatorcontrib>JOAKIM GLAMANN</creatorcontrib><title>COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION</title><description>Described are methods of treating viral disease using compounds that block inhibitory NK cell receptors, thereby reducing their inhibition of NK cell cytotoxicity in killing infected target cells. In one embodiment, the compound is an antibody binding, for example, one or more of the human KIR2DL1, KIR2DL2, and KIR2DL3 receptors. In another embodiment, the method further comprises administering a therapeutic antibody or fusion protein which binds an antigen expressed on cells infected with the virus.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB19vcN8A_2DPH09wtWcPRzUfB1DfHwdwlWcPMPUggJcnUM8fRzVwjzDHL0UfD0c3N1BqnkYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxASGGFsamlsbmrq7GRCgBAL9CJ8o</recordid><startdate>20120625</startdate><enddate>20120625</enddate><creator>FRANCOIS ROMAGNE</creator><creator>PETER ANDREAS NICOLAI REUMERT WAGTMANN</creator><creator>JOAKIM GLAMANN</creator><scope>EVB</scope></search><sort><creationdate>20120625</creationdate><title>COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION</title><author>FRANCOIS ROMAGNE ; PETER ANDREAS NICOLAI REUMERT WAGTMANN ; JOAKIM GLAMANN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT1835937EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FRANCOIS ROMAGNE</creatorcontrib><creatorcontrib>PETER ANDREAS NICOLAI REUMERT WAGTMANN</creatorcontrib><creatorcontrib>JOAKIM GLAMANN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FRANCOIS ROMAGNE</au><au>PETER ANDREAS NICOLAI REUMERT WAGTMANN</au><au>JOAKIM GLAMANN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION</title><date>2012-06-25</date><risdate>2012</risdate><abstract>Described are methods of treating viral disease using compounds that block inhibitory NK cell receptors, thereby reducing their inhibition of NK cell cytotoxicity in killing infected target cells. In one embodiment, the compound is an antibody binding, for example, one or more of the human KIR2DL1, KIR2DL2, and KIR2DL3 receptors. In another embodiment, the method further comprises administering a therapeutic antibody or fusion protein which binds an antigen expressed on cells infected with the virus.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; por
recordid	cdi_epo_espacenet_PT1835937EE
source	esp@cenet
subjects	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T00%3A31%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FRANCOIS%20ROMAGNE&rft.date=2012-06-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT1835937EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true